.Pharmacolibrary.Drugs.V_Various.V04C_OtherDiagnosticAgents.V04CB01_VitaminAConcentrates.VitaminAConcentrates .Pharmacolibrary.Drugs.V_Various.V04C_OtherDiagnosticAgents.V04CB01_VitaminAConcentrates.VitaminAConcentrates| name: | VitaminAConcentrates |
| ATC code: | V04CB01 | route: | oral |
| n-compartments | 1 |
Vitamin A concentrates are formulations of fat-soluble vitamin A (retinol or its esters) used in dietary supplementation or treatment of deficiency. They are administered to prevent or treat vitamin A deficiency, particularly in populations at risk (children, pregnant women) or in cases of malnutrition. Vitamin A is essential for vision, immune function, and cellular growth. These concentrates are approved and used today in clinical practice, mostly as oral or injectable preparations.
No published population pharmacokinetic model exists for 'vitamin A concentrates' as a formulated medicine. The following are estimated typical parameters for adult healthy subjects receiving oral administration of retinyl palmitate, a representative vitamin A ester. These are based on known pharmacokinetic principles and analogous values from retinol studies.
Haskell, MJ, et al., & Brown, KH (2003). Population-based plasma kinetics of an oral dose of [2H4]retinyl acetate among preschool-aged, Peruvian children. The American journal of clinical nutrition 77(3) 681–686. DOI:10.1093/ajcn/77.3.681 PUBMED:https://pubmed.ncbi.nlm.nih.gov/12600861
Zachman, RD, & Chen, XM (1991). Intramuscular relative dose response (RDR) determination of liver vitamin A stores in rats. The Journal of nutrition 121(2) 187–191. DOI:10.1093/jn/121.2.187 PUBMED:https://pubmed.ncbi.nlm.nih.gov/1825326
Rigas, JR, et al., & Warrell, RP (1993). Constitutive variability in the pharmacokinetics of the natural retinoid, all-trans-retinoic acid, and its modulation by ketoconazole. Journal of the National Cancer Institute 85(23) 1921–1926. DOI:10.1093/jnci/85.23.1921 PUBMED:https://pubmed.ncbi.nlm.nih.gov/8230282